AMAaron C. Miller

Aaron C. Miller

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aaron C. Miller has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Estimating the Range and Duration of Post-influenza Symptoms, Conditions, and Diseases

    by Aaron C Miller, D Erik Boonstra, Joseph E Cavanaugh, Roger D Struble, Constantina Boikos, Tianyan Hu, Timothy L Wiemken, Verna L Welch, Philip M Polgreen

    Background: Acute symptoms of influenza are understood; however, less is known about potential postacute sequelae. We conducted a retrospective matched cohort study to identify conditions with elevated risk following influenza. Methods: We analyzed data from the Merative MarketScan Research Databases (2001–2019), including 3.3 million patients with a diagnosis of influenza. Cases were matched 1:1 to patients based on similar age, sex, care setting, and enrollment period with no influenza diagnosis. We examined the frequency of diagnosis codes in the year before and after the index influenza event, applying K-means clustering to identify diagnoses with post-influenza visit patterns similar to cough, a known sequela of influenza. Conditions were reviewed and aggregated into clinical categories. We compared trends in diagnoses between influenza cases and controls using a difference-in-differences approach. Results: We identified 67 diagnostic categories with significantly increased incidence post-influenza infection. Both commonly known sequelae, such as pneumonia and otitis media as well as less expected findings, such as acute kidney failure and oral candidiasis were identified. The duration of elevated risk varied by condition, ranging from a week (eg, rhabdomyolysis) to 5 weeks (eg, hemoptysis) or 8 weeks (eg, chronic bronchitis). Conclusions: We found that influenza is associated with conditions not typically considered. Also, some symptoms last longer than commonly appreciated, suggesting that some patients may suffer from a prolonged illness due to the influenza infection. Our findings have important implications for not only demonstrating the full burden of influenza but also informing future studies to prevent or treat influenza.

  • Open Access

    The incidence, duration, and risk factors for diagnostic delays associated with blastomycosis

    by Desmond D Barber, Roger D Struble, Alan T Arakkal, George R Thompson, John W Baddley, Joseph E Cavanaugh, Aaron C Miller, Philip M Polgreen

    Blastomycosis is a rare, fungal infection often with symptoms resembling bacterial or viral pneumonia, and sometimes lung cancer. Delay in diagnosing blastomycosis is associated with worse clinical outcomes, but factors contributing to diagnostic delays remain poorly understood. This study aims to estimate the incidence and duration of diagnostic delays for blastomycosis and identify risk factors associated with missed diagnostic opportunities. We conducted a retrospective cohort study using longitudinal insurance claims data from the Merative MarketScan Research Databases (2001–2022). Patients with blastomycosis were identified using ICD-9/10 codes, and diagnostic delays were estimated using a case-crossover analysis. We estimated the number of potential missed diagnostic opportunities (i.e., healthcare visits prior to the blastomycosis diagnosis with symptoms suggestive of the disease) and identified potential risk factors for delays. A total of 3825 patients with blastomycosis were identified. Of these, 41% experienced at least one missed diagnostic opportunity, with an average of 3.2 missed visits before diagnosis. The average diagnostic delay was 26.82 days (95% confidence interval: 24.57–28.96), with 17% of patients having delays lasting over a month. Missed opportunities occurred primarily in outpatient settings (59.4%). Risk factors for delayed diagnosis included history of diabetes, prior pulmonary conditions (e.g., chronic obstructive pulmonary disease), and respiratory therapies (e.g., antibiotics, inhalers). Diagnostic delays for blastomycosis are common. The association of delays with pre-existing pulmonary conditions underscore the need for heightened clinical suspicion in patients with respiratory symptoms. Education about risk factors for missed opportunities may be helpful in improving timely diagnosis and hopefully will impact patient outcomes.

  • Open Access

    Evaluating Potential Missed Opportunities to Prevent, Treat, or Diagnose Sepsis: A Population-Based Retrospective Study of Insurance Claims

    by Roger D. Struble, Alan T. Arakkal, Joseph E. Cavanaugh, Philip M. Polgreen, Aaron C. Miller

    IMPORTANCE: Delays in diagnosing sepsis may increase morbidity and mortality, but the frequency of delays is poorly understood. OBJECTIVES: The aim of this study was to estimate the frequency and duration of diagnostic delays for sepsis and potential risk factors for delay. DESIGN, SETTING, AND PARTICIPANTS: We conducted a retrospective case-crossover analysis of sepsis cases from 2016 to 2019 using claims from Merative MarketScan. We ascertained the index diagnosis of sepsis and corresponding hospitalization. We analyzed healthcare visits in the 180 days before diagnosis and then compared the observed and expected trends in signs or symptoms of infection, immune or organ dysfunction (e.g., fever, dyspnea) during the 14 days before diagnosis. A bootstrapping approach was used to estimate the frequency and duration of potential diagnostic delays along with possible risk-factors for experiencing a delay. MAIN OUTCOMES AND MEASURES: The number of patients who experienced a potential diagnostic delay, duration of delay, and number of potential missed opportunities. RESULTS: We identified a total of 649,756 cases of sepsis from 2016 to 2019 meeting inclusion criteria. There was an increase in visits with signs or symptoms of infection, immune or organ dysfunction just before the index diagnosis of sepsis. We estimated that around 16.57% (95% CI, 16.38–16.78) of patients experienced a potential diagnostic delay, with a mean delay duration of 3.21 days (95% CI, 3.13–3.27) and a median of 2 days. Most delays occurred in outpatient settings. Potential diagnostic delays were more frequent among younger age groups and patients who received antibiotics (odds ratio [OR] 2.58 [95% CI, 2.54–2.62]), or treatments for particular symptoms, including opioids (OR 1.43 [95% CI, 1.40–1.46]) and inhalers (OR 1.37 [95% CI, 1.33–1.40]). CONCLUSIONS AND RELEVANCE: There may be a substantial number of potential missed opportunities to diagnose sepsis, especially in outpatient settings. Multiple factors might contribute to delays in diagnosing sepsis including commonly prescribed medications for symptoms.


  • Open Access

    Hospitalizations among family members increase the risk of MRSA infection in a household

    by Aaron C. Miller, Alan T. Arakkal, Daniel K. Sewell, Alberto M. Segre, Bijaya Adhikari, Philip M. Polgreen, For The CDC MInD-Healthcare Group

    Objective: Estimate the risk for household transmission of Methicillin-Resistant Staphylococcus aureus (MRSA) following exposure to infected family members or family members recently discharged from a hospital.Design: Analysis of monthly MRSA incidence from longitudinal insurance claims using the Merative MarketScan Commercial and Medicare (2001–2021) databases.Setting: Visits to inpatient, emergency department, and outpatient settings.Patients: Households with ≥2 family members enrolled in the same insurance plan for the entire month.Methods: We estimated a monthly incidence model, where enrollees were binned into monthly enrollment strata defined by demographic, patient, and exposure characteristics. Monthly incidence within each stratum was computed, and a regression analysis was used to estimate the incidence rate ratio (IRR) associated with household exposures of interest while accounting for potential confounding factors.Results: A total of 157,944,708 enrollees were included and 424,512 cases of MRSA were identified. Across all included enrollees, exposure to a family member with MRSA in the prior 30 days was associated with significantly increased risk of infection (IRR: 71.03 [95% CI, 67.73–74.50]). After removing enrollees who were hospitalized or exposed to a family member with MRSA, exposure to a family member who was recently discharged from the hospital was associated with increased risk of infection (IRR: 1.44 [95% CI, 1.39–1.49]) and the risk of infection increased with the duration of the family member’s hospital stay (P value < .001).Conclusions: Exposure to a recently hospitalized and discharged family member increased the risk of MRSA infection in a household even when the hospitalized family member was not diagnosed with MRSA.


  • The Increase in Household Transmission of Pertussis Associated With Diagnostic Delays

    by Alan T. Arakkal, Joseph E. Cavanaugh, Philip M. Polgreen, Aaron C. Miller

    Background: Pertussis is a highly contagious respiratory illness that can be especially dangerous to young children. Transmission of pertussis often occurs in household settings and is impacted by the timing of treatment and postexposure chemoprophylaxis. This study analyzes the risk for secondary household transmission and if delays in diagnosing pertussis increased the risk for household transmission. Methods: We conducted 2 population-based studies using a large nationally representative administrative claims database. The first study utilized a stratified monthly incidence model to compare the incidence of pertussis among enrollees exposed to a family member with pertussis versus those not exposed. The second study was conducted at a household level following the index case of pertussis in each household. We identified diagnostic delays in the initial household case and used a logistic regression model to evaluate if such delays were associated with a greater risk for transmission. Results: The incidence rate ratio of pertussis was 938.99 [95% confidence interval (CI): 880.19–1001.73] among enrollees exposed to a family member with pertussis relative to those not exposed. The odds of secondary household transmission in households where the index case experienced a diagnostic delay was 5.10 (CI: 4.44–5.85) times the odds of transmission when the index case was not delayed. We found that longer delays were associated with a greater risk for secondary household transmission (P < 0.0001). Conclusions: There is a high rate of secondary transmission of pertussis in household settings. Diagnostic delays increase the likelihood that pertussis will transmit in the household.


  • Open Access

    Cystic Fibrosis Carrier States Are Associated With More Severe Cases of Bronchiectasis

    by Aaron C Miller, Logan M Harris, Kevin L Winthrop, Joseph E Cavanaugh, Mahmoud H Abou Alaiwa, Douglas B Hornick, David A Stoltz, Philip M Polgreen

    People with CF are at increased risk for bronchiectasis and several reports suggest that CF carriers may also be at higher risk for developing bronchiectasis. The purpose of this paper was to determine if CF carriers are at risk for more severe courses or complications of bronchiectasis. Using Marketscan data (2001-2021), we built a cohort consisting of 105 CF carriers with bronchiectasis and 300083 controls with bronchiectasis but without a CF carrier diagnosis. We evaluated if CF carriers were more likely to be hospitalized for bronchiectasis. In addition, we examined if CF carriers were more likely to be infected with Pseudomonas aeruginosa or non-tuberculous mycobacteria (NTM) or to have filled more antibiotic prescriptions. We considered regression models for both incident and rate outcomes that controlled for age, sex, smoking status, and comorbidities. The odds of hospitalization were almost 2.4 times higher (95% CI: 1.116, 5.255) for CF carriers with bronchiectasis compared to non-CF carriers with bronchiectasis. The estimated odds of being diagnosed with a Pseudomonas infection for CF carriers compared to non-carriers was about 4.2 times higher (95% CI 2.417, 7.551) and about 5.4 times higher (95% CI: 3.398, 8.804) for being diagnosed with NTM. The rate of distinct antibiotic fill dates was estimated to be about 2 times higher for carriers compared to controls (95% CI: 1.735 to 2.333), and the rate ratio for the total number of days of antibiotics supplied was estimated to be about 2.8 (95% CI 2.290 to 3.442). CF carriers withbronchiectasis required more hospitalizations and more frequent administration of antibiotics compared to non-carriers. Given that CF carriers were also more likely to be diagnosed with Pseudomonas and NTM infections, CF carriers with bronchiectasis may have a phenotype more resembling CF-related bronchiectasis than non-CF bronchiectasis.


  • Open Access

    Association between household opioid prescriptions and risk for overdose among family members not prescribed opioids

    by Alan T. Arakkal, Linnea A. Polgreen, Cole G. Chapman, Jacob E. Simmering, Joseph E. Cavanaugh, Philip M. Polgreen, Aaron C. Miller

    Background: Prescription opioids have contributed to the rise in opioid‐related overdoses and deaths. The presence of opioids within households may increase the risk of overdose among family members who were not prescribed an opioid themselves. Larger quantities of opioids may further increase risk.Objectives: To determine the risk of opioid overdose among individuals who were not prescribed an opioid but were exposed to opioids prescribed to other family members in the household, and evaluate the risk in relation to the total morphine milligram equivalents (MMEs) present in the household.Methods: We conducted a cohort study using a large database of commercial insurance claims from 2001 to 2021. For inclusion in the cohort, we identified individuals not prescribed an opioid in the prior 90 days from households with two or more family members, and determined the total MMEs prescribed to other family members. Individuals were stratified into monthly enrollment strata defined by household opioid exposure and other confounders. A generalized linear model was used to estimate incidence rate ratios (IRRs) for overdose.Results: Overall, the incidence of overdose among enrollees in households where a family member was prescribed an opioid was 1.73 (95% confidence interval [CI]: 1.67–1.78) times greater than households without opioid prescriptions. The risk of overdose increased continuously with the level of potential MMEs in the household from an IRR of 1.23 (95% CI: 1.16–1.32) for 1–100 MMEs to 4.67 (95% CI: 4.18–5.22) for >12,000 MMEs. The risk of overdose associated with household opioid exposure was greatest for ages 1–2 years (IRR: 3.46 [95% CI: 2.98–4.01]) and 3–5 years (IRR: 3.31 [95% CI: 2.75–3.99]).Conclusions: The presence of opioids in a household significantly increases the risk of overdose among other family members who were not prescribed an opioid. Higher levels of MMEs, either in terms of opioid strength or quantity, were associated with increased levels of risk. Risk estimates may reflect accidental poisonings among younger family members.


  • Diurnal temperature variation and the implications for diagnosis and infectious disease screening: a population-based study

    by Aaron C. Miller, Scott H. Koeneman, Manish Suneja, Joseph E. Cavanaugh, Philip M. Polgreen

    Objectives: Fevers have been used as a marker of disease for hundreds of years and are frequently used for disease screening. However, body temperature varies over the course of a day and across individual characteristics; such variation may limit the detection of febrile episodes complicating the diagnostic process. Our objective was to describe individual variation in diurnal temperature patterns during episodes of febrile activity using millions of recorded temperatures and evaluate the probability of recording a fever by sex and for different age groups. Methods: We use timestamped deidentified temperature readings from thermometers across the US to construct illness episodes where continuous periods of activity in a single user included a febrile reading. We model the mean temperature recorded and probability of registering a fever across the course of a day using sinusoidal regression models while accounting for user age and sex. We then estimate the probability of recording a fever by time of day for children, working-age adults, and older adults. Results: We find wide variation in body temperatures over the course of a day and across individual characteristics. The diurnal temperature pattern differed between men and women, and average temperatures declined for older age groups. The likelihood of detecting a fever varied widely by the time of day and by an individual’s age or sex. Conclusions: Time of day and demographics should be considered when using body temperatures for diagnostic or screening purposes. Our results demonstrate the importance of follow-up thermometry readings if infectious diseases are suspected.


  • Top Cited Papers
    Open Access

    Comparison of Different Antibiotics and the Risk for Community-Associated Clostridioides difficile Infection: A Case–Control Study

    by Aaron C Miller, Alan T Arakkal, Daniel K Sewell, Alberto M Segre, Joseph Tholany, Philip M Polgreen, CDC MInD-Healthcare Group

    Antibiotics are the greatest risk factor for Clostridioides difficile infection (CDI). Risk for CDI varies across antibiotic types and classes. Optimal prescribing and stewardship recommendations require comparisons of risk across antibiotics. However, many prior studies rely on aggregated antibiotic categories or are underpowered to detect significant differences across antibiotic types. Using a large database of real-world data, we evaluate community-associated CDI risk across individual antibiotic types. We conducted a matched case–control study using a large database of insurance claims capturing longitudinal health care encounters and medications. Case patients with community-associated CDI were matched to 5 control patients by age, sex, and enrollment period. Antibiotics prescribed within 30 days before the CDI diagnosis along with other risk factors, including comorbidities, health care exposures, and gastric acid suppression were considered. Conditional logistic regression and a Bayesian analysis were used to compare risk across individual antibiotics. A sensitivity analysis of antibiotic exposure windows between 30 and 180 days was conducted. We identified 159 404 cases and 797 020 controls. Antibiotics with the greatest risk for CDI included clindamycin and later-generation cephalosporins, and those with the lowest risk included minocycline and doxycycline. We were able to differentiate and order individual antibiotics in terms of their relative level of associated risk for CDI. Risk estimates varied considerably with different exposure windows considered. We found wide variation in CDI risk within and between classes of antibiotics. These findings ordering the level of associated risk across antibiotics can help inform tradeoffs in antibiotic prescribing decisions and stewardship efforts.


  • Open Access

    The incidence, duration, risk factors, and age-based variation of missed opportunities to diagnose pertussis: A population-based cohort study

    by Nicholas J. Evans, Alan T. Arakkal, Joseph E. Cavanaugh, Jason G. Newland, Philip M. Polgreen, Aaron C. Miller

    Objective: To estimate the incidence, duration and risk factors for diagnostic delays associated with pertussis.Design: We used longitudinal retrospective insurance claims from the Marketscan Commercial Claims and Encounters, Medicare Supplemental (2001–2020), and Multi-State Medicaid (2014–2018) databases.Setting: Inpatient, emergency department, and outpatient visits.Patients: The study included patients diagnosed with pertussis (International Classification of Diseases [ICD] codes) and receipt of macrolide antibiotic treatment.Methods: We estimated the number of visits with pertussis-related symptoms before diagnosis beyond that expected in the absence of diagnostic delays. Using a bootstrapping approach, we estimated the number of visits representing a delay, the number of missed diagnostic opportunities per patient, and the duration of delays. Results were stratified by age groups. We also used a logistic regression model to evaluate potential factors associated with delay.Results: We identified 20,828 patients meeting inclusion criteria. On average, patients had almost 2 missed opportunities prior to diagnosis, and delay duration was 12 days. Across age groups, the percentage of patients experiencing a delay ranged from 29.7% to 37.6%. The duration of delays increased considerably with age from an average of 5.6 days for patients aged <2 years to 13.8 days for patients aged ≥18 years. Factors associated with increased risk of delays included emergency department visits, telehealth visits, and recent prescriptions for antibiotics not effective against pertussis.Conclusions: Diagnostic delays for pertussis are frequent. More work is needed to decrease diagnostic delays, especially among adults. Earlier case identification may play an important role in the response to outbreaks by facilitating treatment, isolation, and improved contact tracing.